Cargando…

Marked Mild Cognitive Deficits in Humanized Mouse Model of Alzheimer’s-Type Tau Pathology

Hyperphosphorylation and the subsequent aggregation of tau protein into neurofibrillary tangles (NFTs) are well-established neuropathological hallmarks of Alzheimer’s disease (AD) and associated tauopathies. To further examine the impact and progression of human tau pathology in neurodegenerative co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Joshua D., Kim, Yoon A., Rafikian, Elizabeth E., Yang, Mu, Santa-Maria, Ismael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175658/ https://www.ncbi.nlm.nih.gov/pubmed/34093145 http://dx.doi.org/10.3389/fnbeh.2021.634157

Ejemplares similares

Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in physiology and pathology
por: DeFelipe, Javier
Publicado: (2016)

Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer’s disease
por: Sun, Yao, et al.
Publicado: (2021)

Correction to: Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer’s disease
por: Sun, Yao, et al.
Publicado: (2021)

Early Cognitive and Behavioral Deficits in Mouse Models for Tauopathy and Alzheimer’s Disease
por: Samaey, Celine, et al.
Publicado: (2019)

Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
por: Ando, Kunie, et al.
Publicado: (2021)

A Novel hAPP/htau Mouse Model of Alzheimer's Disease: Inclusion of APP With Tau Exacerbates Behavioral Deficits and Zinc Administration Heightens Tangle Pathology
por: Lippi, Stephen L. P., et al.
Publicado: (2018)

Modeling Alzheimer’s disease: considerations for a better translational and replicable mouse model
por: Cho, Joshua D., et al.
Publicado: (2022)

Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain
por: DeVos, Sarah L., et al.
Publicado: (2018)

PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer’s Disease
por: Luna-Viramontes, Nabil Itzi, et al.
Publicado: (2020)

Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks
por: Hansson, Oskar, et al.
Publicado: (2017)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease
por: Zubčić, Klara, et al.
Publicado: (2020)

Machine Learning Decomposition of the Anatomy of Neuropsychological Deficit in Alzheimer’s Disease and Mild Cognitive Impairment
por: Dong, Ningxin, et al.
Publicado: (2022)

Role of Tau Protein in Remodeling of Circadian Neuronal Circuits and Sleep
por: Arnes, Mercedes, et al.
Publicado: (2019)

Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum
por: Chen, Yi-He, et al.
Publicado: (2022)

High Fall Risk Associated With Memory Deficit and Brain Lobes Atrophy Among Elderly With Amnestic Mild Cognitive Impairment and Mild Alzheimer’s Disease
por: Huang, Shuyun, et al.
Publicado: (2022)

EGCG Nanoparticles Attenuate Aluminum Chloride Induced Neurobehavioral Deficits, Beta Amyloid and Tau Pathology in a Rat Model of Alzheimer’s Disease
por: Singh, Neha Atulkumar, et al.
Publicado: (2018)

Dendritic/Post-synaptic Tau and Early Pathology of Alzheimer’s Disease
por: Yin, Xiaomin, et al.
Publicado: (2021)

Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer's Disease Mouse Model
por: Ding, Jiuyang, et al.
Publicado: (2021)

Plasma tau proteins for the diagnosis of mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis
por: Chen, Leian, et al.
Publicado: (2022)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
por: Nowrangi, Milap A., et al.
Publicado: (2015)

Neuroplastin 65 deficiency reduces amyloid plaque formation and cognitive deficits in an Alzheimer’s disease mouse model
por: Wu, Dan-Dan, et al.
Publicado: (2023)

The Impact of Probiotic Supplementation on Cognitive, Pathological and Metabolic Markers in a Transgenic Mouse Model of Alzheimer’s Disease
por: Webberley, Thomas S., et al.
Publicado: (2022)

Passive Immunization With a Novel Monoclonal Anti-PrP Antibody TW1 in an Alzheimer’s Mouse Model With Tau Pathology
por: Boutajangout, Allal, et al.
Publicado: (2021)

Tau pathology epigenetically remodels the neuron-glial cross-talk in Alzheimer’s disease
por: Zhou, Lan-Ting, et al.
Publicado: (2023)

Intranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice
por: Wang, Zigao, et al.
Publicado: (2017)

ALWPs Improve Cognitive Function and Regulate Aβ Plaque and Tau Hyperphosphorylation in a Mouse Model of Alzheimer’s Disease
por: Nam, Youngpyo, et al.
Publicado: (2019)

Narrative Organization Deficit in Lewy Body Disorders Is Related to Alzheimer Pathology
por: Grossman, Murray, et al.
Publicado: (2017)

Sensory processing deficits and related cortical pathological changes in Alzheimer’s disease
por: Zhang, Nicole K., et al.
Publicado: (2023)

Zileuton Improves Memory Deficits, Amyloid and Tau Pathology in a Mouse Model of Alzheimer’s Disease with Plaques and Tangles
por: Chu, Jin, et al.
Publicado: (2013)

Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer’s disease models
por: Corsetti, Veronica, et al.
Publicado: (2020)

Chronic, Mild Hypothermic Environmental Temperature Does Not Ameliorate Cognitive Deficits in an Alzheimer’s Disease Mouse
por: McFadden, Samuel, et al.
Publicado: (2022)

Long-Term Cognitive Impairments and Pathological Alterations in a Mouse Model of Repetitive Mild Traumatic Brain Injury
por: Luo, Jian, et al.
Publicado: (2014)

Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
por: Miao, Jin, et al.
Publicado: (2019)

Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
por: Mullins, Roger J., et al.
Publicado: (2017)

Exercise-Induced Cognitive Plasticity, Implications for Mild Cognitive Impairment and Alzheimer’s Disease
por: Foster, Philip P., et al.
Publicado: (2011)

Mild behavioral impairment linked to progression to Alzheimer’s disease and cortical thinning in amnestic mild cognitive impairment
por: Yoon, Eun Jin, et al.
Publicado: (2023)

Are NSAIDs Useful to Treat Alzheimer's Disease or Mild Cognitive Impairment?
por: Imbimbo, Bruno P., et al.
Publicado: (2010)

Posterior Cortical Cognitive Deficits Are Associated With Structural Brain Alterations in Mild Cognitive Impairment in Parkinson’s Disease
por: Devignes, Quentin, et al.
Publicado: (2021)

Estimation of Tau and Phosphorylated Tau(181) in Serum of Alzheimer’s Disease and Mild Cognitive Impairment Patients
por: Shekhar, Shashank, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_euhjamv11il6gmoqd57ueep8c8